MCMCB Pro
M1183

M1183Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered

HCPCSActiveBETOS Z2

M1183 is a HCPCS Level II code for documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered. It belongs to the Medical Services section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusM

Measurement code. Used for reporting purposes only; never paid.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for M1183

Long descriptor
Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered

The official wording. This is what the code means.

Short descriptor
Doc imm ckpt inhib hld

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2023

When CMS introduced the code.

BETOS
Z2

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to M1183

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1183 is not quite right, the correct code is very often within a few positions of it.

  • M1175Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)
  • M1176Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period
  • M1177Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
  • M1178Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)
  • M1179Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period
  • M1180Patients on immune checkpoint inhibitor therapy
  • M1181Grade 2 or above diarrhea and/or grade 2 or above colitis
  • M1182Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)
  • M1184Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)
  • M1185Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given
  • M1186Patients who have an order for or are receiving hospice or palliative care
  • M1187Patients with a diagnosis of end stage renal disease (esrd)
  • M1188Patients with a diagnosis of chronic kidney disease (ckd) stage 5
  • M1189Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
  • M1190Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
  • M1191Hospice services provided to patient any time during the measurement period

Questions about M1183

What is HCPCS code M1183?

M1183 is a HCPCS Level II code for documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered. It sits in the Medical Services section.

Does Medicare cover M1183?

The CMS HCPCS file marks M1183 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is M1183 paid under the physician fee schedule?

M1183 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.

HCPCS Level II2026Q3-Jul· effective July 1, 2026